TELA Bio
(NASDAQ) TELA
TELA Bio Financials at a Glance
Market Cap
$25.07M
Revenue (TTM)
$80.28M
Net Income (TTM)
$38.83M
EPS (TTM)
$-0.83
P/E Ratio
-0.67
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$0.60
Volume
1,248
Open
$0.60
Price
$0.60
Volume
1,248
Open
$0.60
Previous Close
$0.56
Daily Range
$0.59 - $0.64
52-Week Range
$0.50 - $2.20
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$0.60
Volume
1,248
Open
$0.60
Previous Close
$0.56
Daily Range
$0.59 - $0.64
52-Week Range
$0.50 - $2.20
TELA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TELA Bio
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
218
CEO
Antony Koblish
Website
www.telabio.comHeadquarters
Malvern, PA 19355, US
TELA Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-42%
Net Income Margin
-48%
Return on Equity
-223%
Return on Capital
-53%
Return on Assets
-48%
Earnings Yield
-1.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$25.07M
Shares Outstanding
44.74M
Volume
1.25K
Short Interest
0.00%
Avg. Volume
205.20K
Financials (TTM)
Gross Profit
$54.34M
Operating Income
$33.76M
EBITDA
$33.76M
Operating Cash Flow
$28.22M
Capital Expenditure
$448.00K
Free Cash Flow
$28.67M
Cash & ST Invst.
$50.84M
Total Debt
$55.65M
TELA Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.87M
+18.2%
Gross Profit
$13.76M
+22.6%
Gross Margin
65.91%
N/A
Market Cap
$25.07M
N/A
Market Cap/Employee
$119.94K
N/A
Employees
209
N/A
Net Income
$9.04M
+1.8%
EBITDA
$6.65M
+14.8%
Quarterly Fundamentals
Net Cash
$4.81M
-150.0%
Accounts Receivable
$10.35M
+2.5%
Inventory
$11.02M
-13.8%
Long Term Debt
$55.65M
+30.9%
Short Term Debt
$0.00
-100.0%
Return on Assets
-47.69%
N/A
Return on Invested Capital
-53.21%
N/A
Free Cash Flow
$4.96M
+36.4%
Operating Cash Flow
$4.87M
+35.3%